Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes?

Diabetic Medicine

Volumn 27, Issue 4, 2010, Pages 417-422

  Hermans, M P ^a   Ahn, S A ^a   Amoussou Guenou, K D ^b   Balde, N M ^c   Rousseau, M F ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Endocrinology and Metabolic Diseases Department   (France)

^c Donka Teaching Hospital   (Guinea)

Author keywords

Cardiovascular risk; Ferritin; Insulin resistance; Macroangiopathy; Steatohepatitis

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FERRITIN; FIBRIC ACID DERIVATIVE; GAMMA GLUTAMYLTRANSFERASE; GLITAZONE DERIVATIVE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALBUMINURIA; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; FATTY LIVER; FERRITIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; SMOKING; TRANSIENT ISCHEMIC ATTACK; WAIST CIRCUMFERENCE; BLOOD; COHORT ANALYSIS; CORONARY DISEASE; CROSS-SECTIONAL STUDY; MIDDLE AGED; PHYSIOLOGY; RISK; STROKE;

COHORT STUDIES; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FERRITINS; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREVALENCE; RISK; STROKE;

EID: 77950644284     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.02979.x     Document Type: Article

References (26)

1. Brudevold R, Hole T, Hammerstrøm J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS ONE 2008 3 : e3547.
2. Fernández-Real JM, López-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002 51 : 2348 2354.
3. Fernández-Real JM, Ricart-Engel W, Arroyo E, Balança R, Casamitjana-Abella R, Cabrero D et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998 21 : 62 68.
4. Moore M, Folsom AR, Barnes RW, Eckfeldt JH. No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1995 141 : 719 723.
5. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997 96 : 3300 3307.
6. Bozzini C, Girelli D, Tinazzi E, Olivieri O, Stranieri C, Bassi A et al. Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study. Clin Chem 2002 48 : 622 628.
7. Ma J, Stampfer MJ. Body iron stores and coronary heart disease. Clin Chem 2002 48 : 601 603.
8. You SA, Wang Q. Ferritin in atherosclerosis. Clin Chim Acta 2005 357 : 1 16.
9. Zheng H, Patel M, Cable R, Young L, Katz SD. Insulin sensitivity, vascular function, and iron stores in voluntary blood donors. Diabetes Care 2007 30 : 2685 2689.
10. Lecube A, Hernández C, Pelegrí D, Simó R. Factors accounting for high ferritin levels in obesity. Int J Obes (Lond) 2008 32 : 1665 1669.
11. Friedrich N, Milman N, Völzke H, Linneberg A, Jørgensen T. Is serum ferritin within the reference range a risk predictor of cardiovascular disease? A population-based, long-term study comprising 2874 subjects. Br J Nutr 2009 10 : 1 7.
12. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009 23 : 95 104.
13. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2009 1790 : 671 681.
14. Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR. UKPDS 66: risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. Diabetes Care 2004 27 : 201 207.
15. Hermans MP, Ahn SA, Rousseau MF. Neurohormonal biomarkers and UKPDS stroke risk in type2 diabetic women on primary cardiovascular prevention. Diab Metab Syndr Clin Res Rev 2008 2 : 93 98.
16. Expert Committee. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 : 1183 1197.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 2752.
18. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 : 2191 2192.
19. Hermans MP, Levy JC, Morris RJ, Turner RC. Comparison of insulin sensitivity tests across a range of glucose tolerance form normal to diabetes. Diabetologia 1999 42 : 678 687.
20. Bergman RN. Banting lecture 2006. Orchestration of glucose homestasis. From a small acorn to California oak. Diabetes 2007 56 : 1489 1501.
21. Hermans MP. Diabetic macro- and microvascular disease in type 2 diabetes. Diab Vasc Dis Res 2007 4 : S7 S11.
22. Dehout F, Haumont S, Gaham N, Amoussou-Guenou KD, Hermans MP. Metabolic syndrome in Bantu subjects with type 2 diabetes from sub-Saharan extraction: prevalence, gender differences and HOMA-hyperbolic product. Diabetes Metab Syndr Clin Res Rev 2008 2 : 5 11.
23. Munoko TN, Hermans MP. Phenotypic characterization of first generation Maghrebian migrants with type 2 diabetes: a gender-based comparison with a reference North-Caucasian Belgian cohort. Diabetes Metab Syndr Clin Res Rev 2008 2 : 115 124.
24. Menke A, Fernández-Real JM, Muntner P, Guallar E. The association of biomarkers of iron status with peripheral arterial disease in US adults. BMC Cardiovasc Disord 2009 9 : 34.
25. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F et al. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992 267 : 18148 18153.
26. Hermans MP, Ahn SA, Rousseau MF. Raised natriuretic peptides, Big-endothelin-1 and improved β-cell function in Type 2 diabetic males with hyperuricaemia. Diab Vasc Dis Res 2009 6 : 190 193.